ClariVest Asset Management’s Myriad Genetics MYGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-85,180
| Closed | -$2.37M | – | 715 |
|
2019
Q2 | $2.37M | Sell |
85,180
-600
| -0.7% | -$16.7K | 0.05% | 233 |
|
2019
Q1 | $2.85M | Sell |
85,780
-4,194
| -5% | -$139K | 0.06% | 267 |
|
2018
Q4 | $2.62M | Buy |
89,974
+23,687
| +36% | +$688K | 0.06% | 258 |
|
2018
Q3 | $3.05M | Buy |
66,287
+27,176
| +69% | +$1.25M | 0.05% | 253 |
|
2018
Q2 | $1.46M | Buy |
39,111
+39,092
| +205,747% | +$1.46M | 0.03% | 385 |
|
2018
Q1 | $1K | Hold |
19
| – | – | ﹤0.01% | 691 |
|
2017
Q4 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 676 |
|
2015
Q1 | – | Sell |
-17,585
| Closed | -$599K | – | 629 |
|
2014
Q4 | $599K | Sell |
17,585
-135
| -0.8% | -$4.6K | 0.02% | 267 |
|
2014
Q3 | $683K | Sell |
17,720
-16
| -0.1% | -$617 | 0.03% | 254 |
|
2014
Q2 | $690K | Buy |
+17,736
| New | +$690K | 0.03% | 260 |
|
2013
Q4 | – | Sell |
-76,476
| Closed | -$1.8M | – | 632 |
|
2013
Q3 | $1.8M | Sell |
76,476
-40,984
| -35% | -$963K | 0.08% | 172 |
|
2013
Q2 | $3.16M | Buy |
+117,460
| New | +$3.16M | 0.14% | 144 |
|